Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey.

May 24, 2015 at 12:46 pm

Rev Bras Ter Intensiva. 2015 Jan-Mar;27(1):57-63.

Rabello L1, Conceição C2, Ebecken K1, Lisboa T3, Bozza FA1, Soares M1, Póvoa P2, Salluh JI1.

1Instituto D’Or de Pesquisa e Ensino, Rio de Janeiro, RJ, Brasil.

2Unidade Polivalente de Terapia Intensiva, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, CEDOC, Faculdade Médica NOVA, Nova Universidade de Lisboa, Lisboa, Portugal.

3Unidade de Terapia Intensiva e Comitê de Controle de Infecção, Hospital das Clínicas, Programa de Pós-Graduação em Pneumologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.



This study aimed to evaluate Brazilian physicians’ perceptions regarding the diagnosis, severity assessment, treatment and risk stratification of severe community-acquired pneumonia patients and to compare those perceptions to current guidelines.


We conducted a cross-sectional international anonymous survey among a convenience sample of critical care, pulmonary, emergency and internal medicine physicians from Brazil between October and December 2008. The electronic survey evaluated physicians’ attitudes towards the diagnosis, risk assessment and therapeutic interventions for patients with severe community-acquired pneumonia.


A total of 253 physicians responded to the survey, with 66% from Southeast Brazil. The majority (60%) of the responding physicians had > 10 years of medical experience. The risk assessment of severe community-acquired pneumonia was very heterogeneous, with clinical evaluation as the most frequent approach. Although blood cultures were recognized as exhibiting a poor diagnostic performance, these cultures were performed by 75% of respondents. In contrast, the presence of urinary pneumococcal and Legionella antigens was evaluated by less than 1/3 of physicians. The vast majority of physicians (95%) prescribe antibiotics according to a guideline, with the combination of a 3rd/4th generation cephalosporin plus a macrolide as the most frequent choice.


This Brazilian survey identified an important gap between guidelines and clinical practice and recommends the institution of educational programs that implement evidence-based strategies for the management of severe community-acquired pneumonia.


Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Biología Molecular, CONSENSOS, Epidemiología, GUIDELINES, Infecciones respiratorias, Inmunizaciones, Metodos diagnosticos, REVIEWS, Sepsis.

Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types Management of community-acquired pneumonia in older adults.


May 2015
« Apr   Jun »

Most Recent Posts

%d bloggers like this: